can we improve on xalkori? new agents for patients with an alk-1 rearrangement
Published 11 years ago • 666 plays • Length 6:49Download video MP4
Download video MP3
Similar videos
-
5:52
alk positive forum disease progression xalkori
-
4:58
how do the new alk inhibitor drugs compare to xalkori (crizotinib) for alk lung cancer patients?
-
1:47
alk rearrangements: what are they, and who has them?
-
4:27
alk positive lung cancer forum: xalkori
-
26:56
gracecast-085_lung-cancer_alk inhibition: who to screen and options for alk-positive patients
-
31:43
new ideas and new treatment options for acquired resistance for alk/ros1
-
2:15
new alk inhibitor drugs vs xalkori (crizotinib) for alk lung cancer patients
-
11:02
j-alex trial: should alecensa replace xalkori as first-line alk therapy?
-
37:41
gracecast-044_lung-cancer_camidge on alk inhibitors
-
7:48
alk rearrangements in lung cancer
-
3:35
grace targeted therapies lung cancer 2021 - recommended treatment for an alk variant 1 patient
-
4:14
should a second generation alk inhibitor be first line therapy for patients with alk-positive nsclc?
-
7:49
alk nsclc treatment options - 2022 program: targeted therapies forum
-
17:30
gracecast-084_lung-cancer_alk inhibition: science and early clinical experience by dr. ben solomon
-
1:43
2020 ttf alk session qa panel reducing dosage on lorlatinib vs switching to a different agent
-
1:39
grace targeted therapies lung cancer 2021 - treatment after crizotinib in ros1 lung cancer
-
21:58
grace targeted therapies lung cancer 2021 - alk therapies-which one comes first, how do we sequence?
-
19:47
alk positive forum next generation inhibitors
-
12:50
avastin-containing regimen for first line and maintenance therapy in advanced nsclc